Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 719-728, 2005. First published January 31, 2005; 10.1373/clinchem.2004.044032
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.044032v1
51/4/719    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apostolov, E. O.
Right arrow Articles by Basnakian, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apostolov, E. O.
Right arrow Articles by Basnakian, A. G.
Related Collections
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2005;51:719-728.)
© 2005 American Association for Clinical Chemistry, Inc.

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Quantification of Carbamylated LDL in Human Sera by a New Sandwich ELISA

Eugene O. Apostolov1, Sudhir V. Shah1,3, Ercan Ok1,2 and Alexei G. Basnakian1,a

1 Division of Nephrology, Department of Internal Medicine, University of Arkansas for Medical Sciences Little Rock, AR.
2 Division of Nephrology, Department of Internal Medicine, Ege University Medical School, Bornova, Izmir, Turkey.
3 Renal Medicine Service, Central Arkansas Veterans Healthcare System, Little Rock, AR.

aAddress correspondence to this author at: Division of Nephrology, Department of Internal Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham St., Slot 501, Little Rock, AR 72205. Fax 501-257-4822; e-mail basnakianalexeig{at}uams.edu.

Background: We previously suggested that increased carbamylated LDL (cLDL), a product of nonenzymatic modification of LDL in human serum by urea-derived cyanate, may cause cardiovascular complications in patients with chronic renal insufficiency. An assay for precise measurement of cLDL in serum was not previously available.

Methods: Polyclonal antibodies against human cLDL and nonmodified, native LDL (nLDL) were raised in rabbits and extensively purified by affinity chromatography. New sandwich ELISAs to measure cLDL and nLDL with use of these antibodies were developed. Serum concentrations of cLDL and nLDL were measured by the sandwich ELISAs in 41 patients with end-stage renal disease (ESRD) and 40 healthy controls.

Results: Both assays showed satisfactory reproducibility, linearity, and recovery. The assays could detect 2.7 mg/L cLDL with a linear detection range of 5–1000 mg/L and 5 mg/L nLDL with a linear detection range of 50–1000 mg/L. These measurements showed that patients with ESRD have significantly increased serum cLDL [281.5 (46.9) mg/L compared with 86.1 (29.7) mg/L in a control group; P <0.001]. There was no significant difference in nLDL concentrations between the groups.

Conclusions: These assays are a potentially valuable tool for cardiovascular research in renal patients and healthy individuals. The cLDL concentration appears to be the highest among all previously described modified LDL isoforms in both controls and ESRD patients.




The following articles in journals at HighWire Press have cited this article:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
E. O. Apostolov, S. V. Shah, D. Ray, and A. G. Basnakian
Scavenger Receptors of Endothelial Cells Mediate the Uptake and Cellular Proatherogenic Effects of Carbamylated LDL
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1622 - 1630.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
H. Kastarinen, S. Horkko, H. Kauma, A. Karjalainen, M. J. Savolainen, and Y. A. Kesaniemi
Low-density lipoprotein clearance in patients with chronic renal failure
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2131 - 2135.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
E. O. Apostolov, S. V. Shah, E. Ok, and A. G. Basnakian
Carbamylated Low-Density Lipoprotein Induces Monocyte Adhesion to Endothelial Cells Through Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 826 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
E. O. Apostolov, A. G. Basnakian, X. Yin, E. Ok, and S. V. Shah
Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1836 - H1846.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.